Chatbot Responses to Top Cancer Questions Accurate but Have Limitations

MONDAY, Aug. 28, 2023 (HealthDay News) -- Artificial intelligence (AI) chatbots generally produce accurate information for the top cancer-related web searches, according to a report published online Aug. 24 in JAMA Oncology.
Alexander Pan, from State University of New York Downstate Health Sciences University in Brooklyn, and colleagues assessed the quality of information and presence of misinformation about cancers generated by four AI chatbots. The analysis included 100 text responses to the five most commonly searched queries (Google Trends) related to the five most common cancers (skin, lung, breast, colorectal, and prostate).
The researchers found that the quality of text responses generated by the four AI chatbots was good (median DISCERN score of 5), and no misinformation was identified. Understandability was rated as moderate using the Patient Education Materials Assessment Tool (median understandability score, 66.7 percent), while actionability was poor (median actionability score, 20.0 percent). Based on the Flesch-Kincaid Grade Level score, the responses were written at the college level.
"These limitations suggest that AI chatbots should be used supplementarily and not as a primary source for medical information," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
La apnea del sueño podría provocar un daño directo en el cerebro, encuentra un estudio
VIERNES, 7 de abril de 2023 (HealthDay News) -- La apnea del sueño es un...
Unos hongos del suelo pueden provocar enfermedades, y su extensión aumenta en EE. UU.
LUNES, 21 de noviembre de 2022 (HealthDay News) -- Los hongos que se encuentran...
In Study, Almost Half of Obese Teens Were No Longer So After Taking Wegovy/Ozempic
MONDAY, July 10, 2023 (HealthDay News) -- The drugs Wegovy and Ozempic are all...
Check Smoke, Carbon Monoxide Alarm Batteries as Clocks Go Back on Sunday
THURSDAY, Nov. 3, 2022 (HealthDay News) -- When you set your clocks back on...